Mark your calendars! We have a number of webinars and events coming up, including three this week, that you won’t want to miss. And scroll down for links from our archived webinars.
Braidwood v. Becerra and PrEP Access: Emergency town hall
Tuesday, April 4, 2023, 6:00 PM ET
Especially if you live in the US, join PrEP4All, AVAC, HIV Medicine Association, Center for HIV Law & Policy, Lambda Legal, and other leading advocacy organizations , for an emergency virtual town hall to help the community better understand the implications of a recent US ruling that would block insurers from covering a range of critical preventive services such as PrEP, HIV testing, STI screening, and more. Read AVAC’s statement on the issue.
DRM Learning Collaborative
Thursday, April 6, 2023, 8:00 AM ET / 3:00 PM EAT
The Learning Collaborative is a virtual space that brings together global health advocates, civil society organizations and other key stakeholders from Africa to engage in peer-to-peer learning. This webinar will discuss the landscape including challenges and opportunities, and identify priority advocacy towards expanding local manufacture of vaccines, diagnostics, and therapeutics.
Global PPPR Equity: Why do we need agreements on IP and tech transfers?
Thursday, April 6, 2023, 9:00 AM ET / 2:00 PM GMT / 4:00 PM EAT
Throughout global PPPR agreements in 2023, governments and advocates in the Global South are asking for provisions on equity in the form of temporary IP waivers, mandatory tech transfer, and mandatory licensing for pandemic tools. This webinar will discuss lessons from the HIV epidemic and explore why governments of the Global South and advocates think we still need to address ‘the IP question’. Featured speakers include Fifa Rahman, Brook Baker, Fitsum Lakew, and Esteban Burrone.
Later in April and beyond from The Choice Agenda
How to Communicate about Sexual Health and STIs: Sex positivity vs. risk-based language
Thursday, April 20 at 9:30 AM ET
Our language matters especially when discussing our sexual health. Join The Choice webinar for a conversation focused on sex positivity and risk-based language when discussing sexual health and STIs. Featured speakers include Keosha T. Bond, Joseph Cherabie, and Alison Footman.
HIV Prevention Plus Plus: Developing options that meet the full range of our sexual and reproductive health needs
Tuesday, April 25, 2023 at 9:00 AM ET
With a growing number of PrEP options already, what will it take to bring a new MPTs (Multipurpose Prevention Technology) to market? This webinar from The Choice Agenda will explore what we’ve learned so far on R&D, marketing, counseling and delivery for MPTs – and discuss what we can do now to prepare prevention markets to include new MPT options. Featured speakers include Ruth Akulu, Gregorio Millet, and Thesla Palanee-Phillips.
PrEP (In)equity: Documenting, measuring, and flipping the script towards justice
Tuesday, May 9, 2023, 9:00 AM ET
Disparities in PrEP awareness, access, and uptake are stark in the United States, and play out along lines of race, gender, age, and geography. This webinar from The Choice Agenda will break down some of the existing inequities and key calls to action on how we can better strive for PrEP justice in the US. Featured speakers include Leisha-McKinley Beach, Michael Chancley, and Patrick Sullivan.
PrEP That Booty: The latest on rectal microbicide research for the back door
Thursday, June 29, 2023 at 9:00 AM ET
Researchers and advocates for years have been working on HIV prevention products specifically for the back door (rectum) to provide protection during anal intercourse. This webinar from The Choice Agenda will investigate some of this newfound research with experts working closely in the field. Featured speakers include Jonathan Baker, Craig Hendrix, Juan Michael Porter II and Sharon Riddler.
Be sure to check out recent webinars including Mpox – Sexual Networks, HIV and Activism, a comprehensive recap of this year’s CROI meeting, Been There, Did That – Research Reflections from CROI 2023, and Making PrEP accessible: Updates on long-acting injectable options from International AIDS Society (IAS).